Cargando…

Genetic and clinical analysis in Chinese patients with retinitis pigmentosa caused by EYS mutations

BACKGROUND: Panel‐based targeted exome sequencing was applied to identify the pathogenic variants and genetic characteristics of retinitis pigmentosa (RP) in two Chinese families, and to gain a deeper understanding of the relationship between clinical manifestations and genotypes. METHODS: A total o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yan, Li, Jian‐kang, He, Wei, Wang, Zhuo‐shi, Bai, Jin‐yue, Xu, Ling, Xing, Bo, Zhang, Jian‐guo, Wang, Lusheng, Li, Wei, Chen, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057104/
https://www.ncbi.nlm.nih.gov/pubmed/31944634
http://dx.doi.org/10.1002/mgg3.1117
_version_ 1783503593015345152
author Sun, Yan
Li, Jian‐kang
He, Wei
Wang, Zhuo‐shi
Bai, Jin‐yue
Xu, Ling
Xing, Bo
Zhang, Jian‐guo
Wang, Lusheng
Li, Wei
Chen, Fang
author_facet Sun, Yan
Li, Jian‐kang
He, Wei
Wang, Zhuo‐shi
Bai, Jin‐yue
Xu, Ling
Xing, Bo
Zhang, Jian‐guo
Wang, Lusheng
Li, Wei
Chen, Fang
author_sort Sun, Yan
collection PubMed
description BACKGROUND: Panel‐based targeted exome sequencing was applied to identify the pathogenic variants and genetic characteristics of retinitis pigmentosa (RP) in two Chinese families, and to gain a deeper understanding of the relationship between clinical manifestations and genotypes. METHODS: A total of 17 subjects, comprising two probands (total patients: four subjects) and their family member, were recruited in this study. All subjects underwent comprehensive ophthalmic examinations and clinical evaluations, and the complete history and medical records were collected according to the standard procedures. All participants were screened using the multigene panel test (Target_Eye_792_V2 chip), and Sanger sequencing was used to confirm the candidate variants. RESULTS: Among these two families, a total of three novel mutations in the EYS gene were identified in patients, including a homozygous frameshift mutation c.9252_9253insT detected in two patients in one family, and the compound heterozygous splicesite mutation c.5644+2T>C and frameshift mutation c.1920_1923delTGAG detected in two patients in the another family. All patients in both families had early onset of night blindness and poor visual acuity, and with typical posterior capsule opacification. The mutation co‐segregated within all recruited individuals. In addition, one patient with compound heterozygous mutations was found to have typical blue‐blindness symptoms and detected a previously reported disease‐causing mutation c.235G>A in OPN1SW gene, which caused blue blindness manifestations and was first discovered in patient combined with RP causative genes. CONCLUSIONS: Panel‐based targeted exome sequencing was used to identify three novel variants of RP causative gene, and we also detected a known pathogenic variants of blue‐blindness causative genes in two patients. Our finding will provide a powerful basis for genetic counseling and enhance our current understanding of the genetics factors for RP families.
format Online
Article
Text
id pubmed-7057104
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70571042020-03-12 Genetic and clinical analysis in Chinese patients with retinitis pigmentosa caused by EYS mutations Sun, Yan Li, Jian‐kang He, Wei Wang, Zhuo‐shi Bai, Jin‐yue Xu, Ling Xing, Bo Zhang, Jian‐guo Wang, Lusheng Li, Wei Chen, Fang Mol Genet Genomic Med Original Articles BACKGROUND: Panel‐based targeted exome sequencing was applied to identify the pathogenic variants and genetic characteristics of retinitis pigmentosa (RP) in two Chinese families, and to gain a deeper understanding of the relationship between clinical manifestations and genotypes. METHODS: A total of 17 subjects, comprising two probands (total patients: four subjects) and their family member, were recruited in this study. All subjects underwent comprehensive ophthalmic examinations and clinical evaluations, and the complete history and medical records were collected according to the standard procedures. All participants were screened using the multigene panel test (Target_Eye_792_V2 chip), and Sanger sequencing was used to confirm the candidate variants. RESULTS: Among these two families, a total of three novel mutations in the EYS gene were identified in patients, including a homozygous frameshift mutation c.9252_9253insT detected in two patients in one family, and the compound heterozygous splicesite mutation c.5644+2T>C and frameshift mutation c.1920_1923delTGAG detected in two patients in the another family. All patients in both families had early onset of night blindness and poor visual acuity, and with typical posterior capsule opacification. The mutation co‐segregated within all recruited individuals. In addition, one patient with compound heterozygous mutations was found to have typical blue‐blindness symptoms and detected a previously reported disease‐causing mutation c.235G>A in OPN1SW gene, which caused blue blindness manifestations and was first discovered in patient combined with RP causative genes. CONCLUSIONS: Panel‐based targeted exome sequencing was used to identify three novel variants of RP causative gene, and we also detected a known pathogenic variants of blue‐blindness causative genes in two patients. Our finding will provide a powerful basis for genetic counseling and enhance our current understanding of the genetics factors for RP families. John Wiley and Sons Inc. 2020-01-15 /pmc/articles/PMC7057104/ /pubmed/31944634 http://dx.doi.org/10.1002/mgg3.1117 Text en © 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Sun, Yan
Li, Jian‐kang
He, Wei
Wang, Zhuo‐shi
Bai, Jin‐yue
Xu, Ling
Xing, Bo
Zhang, Jian‐guo
Wang, Lusheng
Li, Wei
Chen, Fang
Genetic and clinical analysis in Chinese patients with retinitis pigmentosa caused by EYS mutations
title Genetic and clinical analysis in Chinese patients with retinitis pigmentosa caused by EYS mutations
title_full Genetic and clinical analysis in Chinese patients with retinitis pigmentosa caused by EYS mutations
title_fullStr Genetic and clinical analysis in Chinese patients with retinitis pigmentosa caused by EYS mutations
title_full_unstemmed Genetic and clinical analysis in Chinese patients with retinitis pigmentosa caused by EYS mutations
title_short Genetic and clinical analysis in Chinese patients with retinitis pigmentosa caused by EYS mutations
title_sort genetic and clinical analysis in chinese patients with retinitis pigmentosa caused by eys mutations
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057104/
https://www.ncbi.nlm.nih.gov/pubmed/31944634
http://dx.doi.org/10.1002/mgg3.1117
work_keys_str_mv AT sunyan geneticandclinicalanalysisinchinesepatientswithretinitispigmentosacausedbyeysmutations
AT lijiankang geneticandclinicalanalysisinchinesepatientswithretinitispigmentosacausedbyeysmutations
AT hewei geneticandclinicalanalysisinchinesepatientswithretinitispigmentosacausedbyeysmutations
AT wangzhuoshi geneticandclinicalanalysisinchinesepatientswithretinitispigmentosacausedbyeysmutations
AT baijinyue geneticandclinicalanalysisinchinesepatientswithretinitispigmentosacausedbyeysmutations
AT xuling geneticandclinicalanalysisinchinesepatientswithretinitispigmentosacausedbyeysmutations
AT xingbo geneticandclinicalanalysisinchinesepatientswithretinitispigmentosacausedbyeysmutations
AT zhangjianguo geneticandclinicalanalysisinchinesepatientswithretinitispigmentosacausedbyeysmutations
AT wanglusheng geneticandclinicalanalysisinchinesepatientswithretinitispigmentosacausedbyeysmutations
AT liwei geneticandclinicalanalysisinchinesepatientswithretinitispigmentosacausedbyeysmutations
AT chenfang geneticandclinicalanalysisinchinesepatientswithretinitispigmentosacausedbyeysmutations